Mirante's Issued and Signed Shirt, Roma-SPAL 2019

关闭

Ended:Friday 13 March EDT 2020 于 11:36

Winner: ANONIMO..

€325($349 USD)

慈善百分比

80%

错过了？

另一个独特的物品可能就在您身边！

联系我们

慈善百分比

80%

奖品

Take home this yellow AS Roma goalkeeper's shirt issued for Italian goalkeeper Antonio Mirante for a match against SPAL on the 16th matchday of Serie A TIM 2019/20.

The game was played at the Stadio Olimpico in Rome on December 15, 2019 and ended in a 3-1 win to home side Roma.

The Serie A football teams played once again to support research on the treatment of rare genetic diseases, this year for the 30th Telethon promoted by the foundation.

Mirante has signed the shirt on the back, making it a unique collector's item.

Features:

Yellow short-sleeved goalkeeper's shirt
Issued for Antonio Mirante
Signed
AS Roma emblem on chest
Sponsored by Nike
Serie A TIM patch on right sleeve
Screen-printed inner label
Name and number in smooth plastic lettering
Number 83
Size L
MatchDay Authenticated inside: C624556352

This item was supplied to the squad for a match, was made available to the players on matchday and differs from the shirts found on general sale.

通过拍卖方式购买独特的物品前还需要买家的仔细评估。我们邀请您在购买之前查看您所掌握的所有信息和资料，包括我们的退货政策。

原因

Since 1990, we have been investing in the best research to find cures for rare genetic diseases. Because these diseases are so rare, often times there is no research being done on them, never mind therapeutic options or a cure.

We want to change this state of affairs because we believe that every person is worth fighting for.

We focus on transforming the results of excellent scientific research projects, selected and supported over time, into accessible treatments.

Finding a cure is not the final destination but a new starting point. We have to make every possible effort to guarantee that successful forms of treatment discovered through the research funded by Telethon are then made available to all patients.

For this reason we also work to develop partnerships with public health care institutions and pharmaceutical companies, so that the results of our research will translate to treatment and medicine accessible to all patients worldwide.

网站